Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?

Onkologie

Volumn 33, Issue 3, 2010, Pages 101-105

  Bilici, Ahmet ^a   Ustaalioglu, Bala B O ^a   Gumus, Mahmut ^a   Seker, Mesut ^a   Yilmaz, Burcak ^a   Kefeli, Umut ^a   Yildirim, Emre ^a   Sonmez, Berkant ^a   Salepci, Taflan ^a   Kement, Metin ^a   Mayadagli, Alpaslan ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gastric cancer; Lymph node metastasis; Metastatic lymph node ratio; Prognosis; Staging

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD VESSEL; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERINEURIUM; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STOMACH CARCINOMA; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; TURKEY;

EID: 77949411867     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000277927     Document Type: Article

References (30)

1. Starzyńska T: Molecular epidemiology of gastric cancer. Dig Dis 2007;25:222-4.
2. Kunisaki C, Makino H, Akiyama H, Otsuka Y, Ono HA, Kosaka T, Takagawa R, Nagahori Y, Takahashi M, Kito F, Shimada H: Clinical significance of the metastatic lymph-node ratio in early gastric cancer. J Gastrointest Surg 2008;12:542-9.
3. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20.
4. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.
5. Kwon SJ, Kim GS: Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach. Br J Surg 1996;83:1600-3.
6. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK: Clinicopathologic characteristics and prognostic factors in 10,783 patients with gastric cancer. Gastric Cancer 1998;1:125-33.
7. Yu W, Choi GS, Whang I, Suh IS: Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 1997;84:1305-9.
8. Fujii K, Isozaki H, Okajima K, Nomura E, Niki M, Sako S, Izumi N, Mabuchi H, Nishiguchi K, Tanigawa N: Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system. Br J Surg 1999;86:685-9.
9. Saito H, Fukumoto Y, Osaki T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M: Prognostic significance of level and number of lymph node metastases in patients with gastric cancer. Ann Surg Oncol 2007; 14:1688-93.
10. Japanese Gastric Cancer Association: Japanese classification of gastric cancer, 2nd English ed. Gastric Cancer 1998;1:10-24.
11. Sobin LH, Wittekind CH: TNM Classification of Malignant Tumors, 5th ed. New York, John Wiley&Sons, 1997.
12. Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T: Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma. Cancer 2000;88:1796-800.
13. Karpeh MS, Leon L, Klimstra D, Brennan MF: Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg 2000;232:362-71.
14. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M: Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003;10:1077-85.
15. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K: Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9:775-84.
16. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I, Meyer S, Plukker JT, Van Elk P, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H; Dutch Gastric Cancer Group: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908-14.
17. Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K, Okumura S, Yamamichi K, Hioki K: The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002;9:27-34.
18. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Kito T: Metastatic gastric lymph node rate is a significant prognostic factor for resectable stage IV stomach cancer. J Am Coll Surg 1997;185:65-9.
19. Takagane A, Terashima M, Abe K, Araya M, Irinoda T, Yonezawa H, Nakaya T, Inaba T, Oyama K, Fujiwara H, Saito K: Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer. Gastric Cancer 1999;2: 122-8.
20. Hyung WJ, Noh SH, Yoo CH, Huh JH, Shin DW, Lah KH, Lee JH, Choi SH, Min JS: Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 2002;26:323-9.
21. Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Ono H, Akiyama H: Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res 2005;25:1369-75.
22. Rodríguez Santiago JM, Muñoz E, Martí M, Quintana S, Veloso E, Marco C: Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol 2005;31:59-66.
23. Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, Roviello F, de Manzoni G, Minicozzi A, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D; Italian Research Group for Gastric Cancer (IRGGC): The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1,853 patients. Ann Surg 2007;245:543-52.
24. Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D'Ugo D: Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol 2008;34:519-24.
25. Celen O, Yildirim E, Berberoglu U: Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol 2007;96:95-101.
26. Saito H, Fukumoto Y, Osaki T, Yamada Y, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M: Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 2008; 97:132-5.
27. Metz CE: Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-98.
28. Adachi Y, Kamakura T, Mori M, Baba H, Maehara Y, Sugimachi K: Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 1994;81:414-6.
29. Ichikura T, Tomimatsu S, Okusa Y, Uefuji K, Tamakuma S: Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol 1993; 11:1894-900.
30. Hayashi H, Ochiai T, Suzuki T, Shimada H, Hori S, Takeda A, Miyazawa Y: Superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery 2000;127:129-35.